US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,567.99

-10.0364-0.64%

Number of Gainers:- -

Number of Losers:7

Number of Flat:- -

PE:- -

High:1,590.89

Open:1,579.34

Low:1,558.46

Close:1,578.03

Volume:63.28M

Turnover:5.40B

Market Cap:1.63T

Float Cap:1.57T

Loading ...

Oura Files for Initial Public Offering on Nasdaq

MT Newswires Live

Novo Nordisk's Weight-Loss, Diabetes Drug Candidate Meets Primary Goals

MT Newswires Live

Goldman Sachs Sticks to Their Hold Rating for Novo Nordisk (0QIU)

Oura - Eli Lilly Interested in Purchasing up to $100 Mln; Dragoneer up to $300 Mln in IPO - SEC Filing

THOMSON REUTERS

Novo Says Its Next-Gen Obesity Drug Tops Lilly Rival in Late-Stage Study

Why Is Novo Stock (NVO) Falling in Pre-Market Today, September 21?

Novo Nordisk Drops Over 7% Pre-Market as Wegovy Sales Miss Expectations

Market Chatter: Novo Nordisk Urged by Shareholders to Develop New Medicines, Pursue Acquisitions

MT Newswires Live

Pfizer Agrees to Share Incremental Overseas Drug Revenue With HHS

MT Newswires Live

Novo Nordisk Aims for $23 Billion in 2035 Pipeline Sales

MT Newswires Live

Novo Nordisk Stock Tumbles as Ozempic Maker Sets Out 2030 Goals

Wegovy Maker Novo Nordisk Targets Several New Blockbuster Drugs in Coming Years

Sino Biopharmaceutical Stock Rises 8.2% in Hong Kong, Outperforms Competitors

Pfizer to share portion of increased revenue to U.S. HHS, Bloomberg says

Eli Lilly, Novo sued over risk of sudden vision loss, WSJ reports

Will Conference Outlook Change Pfizer (PFE) Stock Narrative

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/BK4599/news?page=15"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"Weight Loss Drugs","latestPrice":1567.9943,"timestamp":1790971199999,"preClose":1578.0306,"halted":0,"volume":63277927,"delay":0,"changeRate":-0.00636,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-10.036377,"latestTime":"10-02 16:00:00 EDT","open":1579.339,"high":1590.8905,"low":1558.4647,"amount":5402065307.321307,"amplitude":0.020548,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":9.58996,"peRate":28.239741,"turnoverRate":0.005949,"increases":0,"decrements":7,"flats":0,"marketCap":1628153847712,"floatMarketCap":1570705071680},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1590.8905,"amplitude":0.020548,"preClose":1578.0306,"low":1558.4647,"pbRate":"9.58996","latestPrice":1567.9943,"volume":63277927,"delay":0,"open":1579.339,"prevYearClose":1494.5856,"prevWeekClose":1622.7886,"prevMonthClose":1599.3274,"prevQuarterClose":1599.3274,"fiveDayClose":1622.7886,"twentyDayClose":1648.1235,"sixtyDayClose":1637.6415,"secType":"PLATE","market":"US","turnoverRate":0.005949,"peRate":28.239741,"marketCap":1628153847712,"floatMarketCap":1570705071680,"timestamp":1790971199999,"nameCN":"Weight Loss Drugs"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":0,"down":7,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:15,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669168714","title":"Oura Files for Initial Public Offering on Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2669168714","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669168714?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:48","pubTimestamp":1789991318,"startTime":"0","endTime":"0","summary":"Oura and some of its shareholders plan to offer 50 million common shares at an estimated price of $40 to $44 per share in an initial public offering, the smart ring maker said Monday in a Form S-1 filing.Oura is offering 13.5 million shares, while selling shareholders are offering 36.5 million shares. The underwriters have an option to purchase up to an additional 7.5 million shares from the selling shareholders.The company expects to have 320.9 million shares outstanding immediately after the offering, it said. Oura has applied to list on the Nasdaq Global Select Market under the ticker \"OURA.\"Oura estimates net proceeds of approximately $532.6 million, based on an assumed IPO price of $42 per share.The company plans to use around $526.4 million of the proceeds to cover expected tax withholding and remittance obligations associated with the net settlement of restricted stock units.The remainder will fund general corporate purposes, including technology development, working capital, op","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","IE00BJJMRX11.SGD","FTXH","LU0289739699.SGD","LU0316494557.USD","IE0005OL40V9.USD","LU1232071149.USD","LU1323610961.USD","BK4599","IE0002141913.USD","LU1145028129.USD","LU1035775433.USD","SG9999014898.SGD","LU2471134523.USD","LU2552382058.USD","LU0820562030.AUD","MHIP","LU0198837287.USD","IE00B2B36J28.USD","LU0889565916.HKD","LU0106261372.USD","LLYX","LU2491050154.USD","BK4588","CANC","LU1989771016.USD","LU2112291526.USD","AGNG","LU2271345857.HKD","LU2023250504.SGD","LU0323591593.USD","LU0353189763.USD","LU1917777945.USD","LU2237443465.HKD","LU2357305700.SGD","LU0345770308.USD","LU0823434740.USD","LU1057294990.SGD","LU1623119135.USD","LU0158827781.USD","IE00B1BXHZ80.USD","LU2168564065.EUR","LU2213496289.HKD","SG9999015952.SGD","LU1551013342.USD","LU0061475181.USD","LU0058720904.USD","SGXZ81514606.USD","IYH","LU0234572021.USD","ELIS","LU0006306889.USD","LU0882574055.USD","LU0109391861.USD","LU2089283258.USD","LU0097036916.USD","LU2756315318.SGD","LU0708995401.HKD","LU2089984988.USD","SG9999015978.USD","LU2111349929.HKD","LU1548497426.USD","LU2746668461.USD","LU0466842654.USD","LU2750360997.AUD","LU0210536198.USD","MEDX","LU2063271972.USD","SG9999013999.USD","LU0943347566.SGD","IHE","IE00BJLML261.HKD","IE00BFSS8Q28.SGD","LU0882574139.USD","LU2471134796.USD","LU0640476718.USD","LU0122379950.USD","LU0432979614.USD","LU0823416689.USD","LU1814569148.SGD","LU0225283273.USD","LU1868836914.USD","LU2023250330.USD","LU1629891620.HKD","LU2265009873.SGD","LU0079474960.USD","LU1280957306.USD","GB00BDT5M118.USD","LU2168564222.USD","IE00BFSS7M15.SGD","LU2211815571.USD","SG9999014906.USD","LU2237443978.SGD","JDOC","LU2462591350.SGD","LU0964807845.USD","LU2461242641.AUD","LU2471134879.HKD","LU2552382215.SGD","LU2552382132.HKD","LU0203202063.USD","LU0345770993.USD","LU1291159041.SGD","LU2491050071.SGD","LLY","LU1267930730.SGD","LLII","SG9999014914.USD","TRUH","LU1127390331.HKD","VHT","LU1868837136.USD","LU2023251221.USD","SG9999015986.USD","LU0256863902.USD","SGXZ51526630.SGD","IE00B1XK9C88.USD","IE00BFTCPJ56.SGD","LU1093756325.SGD","LU2236285917.USD","LU2237443895.HKD","LU2361044949.HKD","LU0672654240.SGD","LU1366192091.USD","IE00BJJMRY28.SGD","LU0158827948.USD","SG9999014880.SGD","LU2089284900.SGD","LU1023059063.AUD","ELIL","LU2324357040.USD","LU0266013472.USD","SGXZ31699556.SGD","OURA","LU2237443382.USD","PJP","LU0238689110.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU0354030438.USD","IE00BKPKM429.USD","LU0094547139.USD","LU1720051017.SGD","IE00BJT1NW94.SGD","SG9999001176.SGD","LU2468319806.SGD","LU1988902786.USD","LU2360106947.USD","TMED","LU2361045086.USD","HRTS","LU1712237335.SGD","SG9999018857.SGD","LU2168563687.JPY","SGXZ57979304.SGD","LU1868836591.USD","LU2896262040.SGD","LU1868836757.USD","LU0417517546.SGD","LU0823434583.USD","LU2168564149.EUR","LU2264538146.SGD","IE0009355771.USD","LU0385154629.USD","LU2417539215.USD","LU2237443549.SGD","LU2756315664.SGD","IE00BKDWB100.SGD","RXL","IE0004445015.USD","LU0133085943.USD","LU1979441026.SGD","LU2106854487.HKD","IE00BK4W5L77.USD","LU0471298777.SGD","IE00B7KXQ091.USD","CURE","ILDR","LU0689472784.USD","LU0096364046.USD","LU0256863811.USD","BK4516","LU1551013425.SGD","IE0001KFT4U8.USD","WDNA","LU0203201768.USD","LU2602419157.SGD","LU0683600562.USD","LU2168564495.EUR","IE00BN29S564.USD","LU0114720955.EUR","LU0320765992.SGD","SG9999018865.SGD","LU1064131342.USD","LU1691799644.USD","LU0109394709.USD","FHLC","SG9999017495.SGD","THNR","MEDI","IE00B4JS1V06.HKD","LU0320765059.SGD","BK4534","IE00BWXC8680.SGD","LU1983299246.USD","LU2237438978.USD","LU2746668974.SGD","LU1720051108.HKD","LU0787776722.HKD","OZEM","LLYZ","LU1061106388.HKD","LU0353189680.USD","LU0820561909.HKD","GDOC","BK4581","LU0456855351.SGD","LU1974910355.USD","LU1804176565.USD","LU2491049909.HKD","IXJ","LU0174119429.USD","IE00BK4W5M84.HKD","SG9999001176.USD","LU2456880835.USD","IE00B775H168.HKD","LU1868837300.USD","LU2750360641.GBP","LU2462157665.USD","LU0820561818.USD","LU2237443622.USD","LU2471134952.CNY","SG9999015945.SGD","LU1093756168.USD","LU0786609619.USD","LU2361044865.SGD","PPH","BK4533","LU1069344957.HKD","LU2087625088.SGD","SGXZ99366536.SGD","XLV","LU2028103732.USD","LU0354030511.USD","LU2108987350.USD","IE0004445239.USD","LU0471298694.HKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669168766","title":"Novo Nordisk's Weight-Loss, Diabetes Drug Candidate Meets Primary Goals","url":"https://stock-news.laohu8.com/highlight/detail?id=2669168766","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669168766?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:46","pubTimestamp":1789991192,"startTime":"0","endTime":"0","summary":"Novo Nordisk's  investigational once-weekly weight-loss and diabetes treatment CagriSema was superior to tirzepatide and met its primary superiority endpoint in two phase 3 trials, respectively, the company said Monday.In one study, CagriSema achieved an average weight loss of 12.4%, compared with 9.1% for tirzepatide, the company said.In the other study, CagriSema provided a weight reduction of 21% versus 2% for a placebo, the company said. CagriSema also showed improvements compared with the placebo in other prespecified supportive endpoints including blood pressure, waist-to-height ratio, and fasting lipid profile, the company said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1093756325.SGD","NVOX","BK4599","NVOC","OZEM","NVO","PPH","THNR","IE00BZ1G4Q59.USD","BK4585","BK4532","IE00BKVL7J92.USD","BK4007","LU0154236417.USD","LU1093756168.USD","NVOH","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669168498","title":"Goldman Sachs Sticks to Their Hold Rating for Novo Nordisk (0QIU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669168498","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669168498?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:25","pubTimestamp":1789989926,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst James Quigley maintained a Hold rating on Novo Nordisk today and set a price target of DKK285.00. According to TipRanks, Quig...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/goldman-sachs-sticks-to-their-hold-rating-for-novo-nordisk-0qiu-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/goldman-sachs-sticks-to-their-hold-rating-for-novo-nordisk-0qiu-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BKVL7J92.USD","BK4588","LU1093756325.SGD","BK4599","OZEM","THNR","NVO","NVOH","BK4007","NVOX","IE00BZ1G4Q59.USD","LU0154236417.USD","NVOC","PPH","BK4585","BK4532","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669150396","title":"Oura - Eli Lilly Interested in Purchasing up to $100 Mln; Dragoneer up to $300 Mln in IPO - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2669150396","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669150396?lang=en_us&edition=fundamental","pubTime":"2026-09-21 18:56","pubTimestamp":1789988165,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45C050:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LLII","LU1989771016.USD","LU1868837300.USD","SG9999018857.SGD","LU0823434583.USD","LU2468319806.SGD","BK4585","LU1145028129.USD","IE0001KFT4U8.USD","BK4588","IE00B7KXQ091.USD","ELIS","LU2108987350.USD","LU0354030511.USD","IE00BJJMRZ35.SGD","LU0823434740.USD","LU1868836914.USD","SG9999014914.USD","GDOC","LU0061475181.USD","LU2471134879.HKD","LU0889565916.HKD","LU2361044865.SGD","LU2746668974.SGD","LU1023059063.AUD","LU0203202063.USD","SG9999013999.USD","LU0320765059.SGD","LU0466842654.USD","LU1720051017.SGD","OZEM","LU2089284900.SGD","LU2491050154.USD","SGXZ51526630.SGD","SG9999018865.SGD","LU0079474960.USD","IE0002141913.USD","JDOC","LU1061106388.HKD","IXJ","IE00BJJMRX11.SGD","LU0225283273.USD","LU2111349929.HKD","LU2168563687.JPY","LU1712237335.SGD","LU1814569148.SGD","LU2456880835.USD","LU2106854487.HKD","PPH","LU1366192091.USD","LU2023250504.SGD","BK4599","VHT","LU0471298777.SGD","AGNG","LU2237443622.USD","LU0109394709.USD","LU2168564222.USD","LU2168564495.EUR","LU2462591350.SGD","IE0009355771.USD","LU0094547139.USD","IE00BKDWB100.SGD","SG9999017495.SGD","FHLC","LU2471134796.USD","IE0005OL40V9.USD","LU2552382215.SGD","LU1868837136.USD","MHIP","LU0683600562.USD","LU1974910355.USD","LU0096364046.USD","CURE","SGXZ57979304.SGD","LU0786609619.USD","IE00BFSS8Q28.SGD","BK4581","LU0787776722.HKD","LU1868836591.USD","LU0058720904.USD","LLYZ","LU0174119429.USD","LU2168564149.EUR","IE00BJJMRY28.SGD","LU2265009873.SGD","LU2471134952.CNY","XLV","LU0133085943.USD","LU2360106947.USD","LU0882574055.USD","HRTS","TMED","IE0004445015.USD","LU0689472784.USD","IE0004445239.USD","LU0256863811.USD","LU0672654240.SGD","SG9999014906.USD","SGXZ81514606.USD","LU0820561818.USD","LU2324357040.USD","LU2063271972.USD","LU0823416689.USD","LU0353189680.USD","IE00B1XK9C88.USD","RXL","PJP","SG9999001176.USD","LU0345770308.USD","SG9999014880.SGD","LU0266013472.USD","LU0456855351.SGD","LU2168564065.EUR","LU2750360641.GBP","LU1551013342.USD","GB00BDT5M118.USD","LU2461242641.AUD","LU2471134523.USD","LU0203201768.USD","LU1069344957.HKD","LU2756315664.SGD","LU1323610961.USD","LU0882574139.USD","IE00BFSS7M15.SGD","LU0198837287.USD","LU0943347566.SGD","LU0471298694.HKD","LU0234572021.USD","LU2361044949.HKD","LU0006306889.USD","LU0353189763.USD","LU1868836757.USD","LU1232071149.USD","LU2089984988.USD","BK4534","LU1057294990.SGD","OURA","LU2491050071.SGD","LU2896262040.SGD","LU2023250330.USD","LU0964807845.USD","LU0320765992.SGD","LU2237443549.SGD","MEDX","LU1720051108.HKD","LU2746668461.USD","LU0354030438.USD","IE00BFTCPJ56.SGD","LU0708995401.HKD","LU2236285917.USD","LU0385154629.USD","LU0158827781.USD","IHE","LU1267930730.SGD","SG9999001176.SGD","LU0417517546.SGD","LU0106261372.USD","LU2417539215.USD","TRUH","ILDR","SGXZ99366536.SGD","LU0345770993.USD","LU0820562030.AUD","SG9999015986.USD","LU1623119135.USD","LU2491049909.HKD","IE00BK4W5M84.HKD","CANC","LU1551013425.SGD","LU0640476718.USD","LU2237443978.SGD","WDNA","IE00BJT1NW94.SGD","SGXZ31699556.SGD","LU1064131342.USD","LU0109391861.USD","LU2112291526.USD","LU2361045086.USD","LU2750360997.AUD","LU2462157665.USD","LU2211815571.USD","LU0114720955.EUR","IE00BWXC8680.SGD","SG9999015978.USD","LU0238689110.USD","SG9999014898.SGD","LU0256863902.USD","LU2213496289.HKD","LU2237443382.USD","IYH","LU0122379950.USD","LU1127390331.HKD","LU2028103732.USD","IE00B2B36J28.USD","LU2089283258.USD","FTXH","LU1093756168.USD","BK4533","LU2271345857.HKD","LU0316494557.USD","IE00B4JS1V06.HKD","LU2087625088.SGD","LU1548497426.USD","SG9999015945.SGD","LU0210536198.USD","LU1291159041.SGD","BK4516","LLY","IE00BK4W5L77.USD","LU0432979614.USD","BK4007","LU1691799644.USD","LU2023251221.USD","LU2602419157.SGD","IE00BN29S564.USD","MEDI","IE00BJLML261.HKD","LU0158827948.USD","LU1035775433.USD","LU0097036916.USD","LU1804176565.USD","LLYX","THNR","LU2237443895.HKD","IE00BKPKM429.USD","LU2756315318.SGD","LU2237443465.HKD","IE00B4R5TH58.HKD","LU2237438978.USD","LU2264538146.SGD","LU0289739699.SGD","LU1988902786.USD","LU1629891620.HKD","LU1983299246.USD","LU1093756325.SGD","SG9999015952.SGD","LU1979441026.SGD","IE00B1BXHZ80.USD","LU2552382058.USD","LU2552382132.HKD","LU2357305700.SGD","IE00B775H168.HKD","LU1280957306.USD","LU0323591593.USD","LU1917777945.USD","ELIL","LU0820561909.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669157222","title":"Novo Says Its Next-Gen Obesity Drug Tops Lilly Rival in Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2669157222","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669157222?lang=en_us&edition=fundamental","pubTime":"2026-09-21 18:44","pubTimestamp":1789987466,"startTime":"0","endTime":"0","summary":"Novo says its next-gen obesity drug tops Lilly rival in late-stage studySept 21 (Reuters)-Novo NordiskNOVOb.COsaid on Monday its next-generation experimental drug had achieved an estimated average weight loss of 12.4% in a late-stage trial and that it was superior to Eli Lilly'sLLY.Ndrug.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nL4N45D0OB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","LU1057294990.SGD","LU0133085943.USD","LU1291159041.SGD","SGXZ51526630.SGD","LU1551013425.SGD","LU0943347566.SGD","ELIS","LU1983299246.USD","LU2471134879.HKD","LU2168564065.EUR","LU0114720955.EUR","LU0203201768.USD","LU2237443549.SGD","LU0203202063.USD","LU1868836757.USD","LU0256863902.USD","LU2237443978.SGD","SG9999014898.SGD","LU2361044865.SGD","SG9999015952.SGD","LU0320765059.SGD","LU2023250330.USD","LU0238689110.USD","LU2324357040.USD","LU1989771016.USD","LU2237443465.HKD","LU0823434740.USD","OZEM","LU1280957306.USD","SGXZ99366536.SGD","LU0154236417.USD","LU0820561818.USD","LU0820561909.HKD","THNR","LU1061106388.HKD","LU2456880835.USD","LU2264538146.SGD","BK4534","LU0266013472.USD","TMED","LU0320765992.SGD","LU2552382132.HKD","LU0354030511.USD","LU2461242641.AUD","IE00BJJMRY28.SGD","LU0471298694.HKD","LU0234572021.USD","LU0353189763.USD","SG9999015945.SGD","LU0820562030.AUD","SG9999017495.SGD","LU2417539215.USD","SG9999015978.USD","LU0174119429.USD","IE00BWXC8680.SGD","LU1868836591.USD","LU2462591350.SGD","SG9999015986.USD","LU1623119135.USD","LU0823416689.USD","SGXZ81514606.USD","LU2552382058.USD","LU2552382215.SGD","LU2023250504.SGD","LU2357305700.SGD","LU0061475181.USD","LU2746668974.SGD","LU2168564222.USD","LU2213496289.HKD","LU0094547139.USD","LU1093756168.USD","BK4532","LU2106854487.HKD","LU2168564149.EUR","IE00BFSS8Q28.SGD","LLY","MHIP","ELIL","LU2271345857.HKD","LU0683600562.USD","BK4516","LU0006306889.USD","FTXH","IE00BFTCPJ56.SGD","LU2237443622.USD","LU0158827781.USD","LU2112291526.USD","IE00BZ1G4Q59.USD","IE00BJT1NW94.SGD","LU0708995401.HKD","NVOH","LU0786609619.USD","LU0471298777.SGD","LU0823434583.USD","MEDI","LU2089984988.USD","LU1069344957.HKD","JDOC","LU2111349929.HKD","LU2361045086.USD","NVO","IE00BKDWB100.SGD","LU1064131342.USD","LU1974910355.USD","LU1988902786.USD","LU2028103732.USD","LU2746668461.USD","IE00BK4W5M84.HKD","LU2023251221.USD","LU1127390331.HKD","LU0289739699.SGD","LU0109394709.USD","IYH","LU0456855351.SGD","LU1093756325.SGD","SGXZ31699556.SGD","LU0345770993.USD","SG9999018865.SGD","IE00B4JS1V06.HKD","LU0432979614.USD","CANC","HRTS","IE00BKVL7J92.USD","ILDR","IE00BK4W5L77.USD","LU2237443895.HKD","LU0225283273.USD","LU1979441026.SGD","IE00B1XK9C88.USD","XLV","LU2462157665.USD","SG9999014906.USD","RXL","LU0256863811.USD","LU0353189680.USD","LU2471134523.USD","LU0672654240.SGD","PJP","LU1917777945.USD","LU2087625088.SGD","LU1145028129.USD","LU2237443382.USD","LU0210536198.USD","LU0385154629.USD","SG9999013999.USD","LU0198837287.USD","LU0689472784.USD","LU0417517546.SGD","LU2491049909.HKD","LU2168564495.EUR","IE00BJLML261.HKD","IE00B1BXHZ80.USD","LU1868837136.USD","LU0787776722.HKD","LU0109391861.USD","LU0964807845.USD","SG9999001176.SGD","LU0466842654.USD","AGNG","LU2063271972.USD","LU1548497426.USD","LU2750360997.AUD","IE00BN29S564.USD","LU0058720904.USD","LU2211815571.USD","LU1691799644.USD","BK4581","LLII","LU0316494557.USD","LU1551013342.USD","LU1868837300.USD","LU2468319806.SGD","GB00BDT5M118.USD","LU2108987350.USD","LU2471134796.USD","TRUH","LU2089283258.USD","IE0009355771.USD","IXJ","LU2237438978.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU1804176565.USD","LU0323591593.USD","LU1323610961.USD","SG9999014880.SGD","LU2168563687.JPY","SGXZ57979304.SGD","LU2089284900.SGD","LU0889565916.HKD","BK4588","LU1267930730.SGD","LU1035775433.USD","LU1712237335.SGD","LU0079474960.USD","IE0001KFT4U8.USD","IE0004445015.USD","LU1720051108.HKD","MEDX","LU0882574055.USD","LU2750360641.GBP","IE00B7KXQ091.USD","LU0097036916.USD","LU2756315318.SGD","CURE","SG9999001176.USD","GDOC","LLYX","LU0640476718.USD","LU0345770308.USD","LU1629891620.HKD","LU1720051017.SGD","SG9999014914.USD","LU2236285917.USD","SG9999018857.SGD","FHLC","LU2360106947.USD","BK4007","BK4533","IE00BFSS7M15.SGD","LU0122379950.USD","LU0882574139.USD","LU2491050071.SGD","LU1023059063.AUD","LU2896262040.SGD","LU2361044949.HKD","WDNA","LU1814569148.SGD","IE00BJJMRX11.SGD","LU1868836914.USD","LU0354030438.USD","LLYZ","NVOX","VHT","IE00B775H168.HKD","LU2471134952.CNY","IHE","LU2491050154.USD","LU0096364046.USD","LU1232071149.USD","PPH","LU2602419157.SGD","IE0004445239.USD","LU0158827948.USD","IE00BKPKM429.USD","LU1366192091.USD","BK4585","BK4599","LU2756315664.SGD","NVOC","IE00BJJMRZ35.SGD","IE0005OL40V9.USD","LU2265009873.SGD","LU0106261372.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669506111","title":"Why Is Novo Stock (NVO) Falling in Pre-Market Today, September 21?","url":"https://stock-news.laohu8.com/highlight/detail?id=2669506111","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669506111?lang=en_us&edition=fundamental","pubTime":"2026-09-21 18:40","pubTimestamp":1789987202,"startTime":"0","endTime":"0","summary":"Shares of Danish drug giant Novo ($NVO) dropped more than 5% to around $41 in Monday’s pre-market session. The decline came after CEO Mike Doustdar...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/novo-stock-nvo-is-falling-in-pre-market-today-september-21-heres-why?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/novo-stock-nvo-is-falling-in-pre-market-today-september-21-heres-why?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BKVL7J92.USD","NVOH","IE00BZ1G4Q59.USD","LU0154236417.USD","NVO","THNR","LU1093756325.SGD","BK4007","BK4532","LU1093756168.USD","OZEM","BK4585","PPH","NVOC","BK4599","NVOX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669152858","title":"Novo Nordisk Drops Over 7% Pre-Market as Wegovy Sales Miss Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2669152858","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669152858?lang=en_us&edition=fundamental","pubTime":"2026-09-21 17:49","pubTimestamp":1789984163,"startTime":"0","endTime":"0","summary":"TradingKey - On September 21, Novo Nordisk (NVO) dropped over 7% at one point in US pre-market trading. According to the company's latest financial results, while full-year sales and profit guidance improved from previous projections, sales performance of its core weight-loss drug Wegovy still missed market expectations, serving as the primary drag on the stock.","market":"other","thumbnail":"https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/analysis/stocks/us-stocks/262178042-novo-nordisk-slides-premarket-wegovy-sales-miss-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4532","NVOH","LU1093756168.USD","NVOC","IE00BZ1G4Q59.USD","LU0154236417.USD","PPH","IE00BKVL7J92.USD","BK4588","BK4585","LU1093756325.SGD","OZEM","BK4599","NVOX","THNR","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669154261","title":"Market Chatter: Novo Nordisk Urged by Shareholders to Develop New Medicines, Pursue Acquisitions","url":"https://stock-news.laohu8.com/highlight/detail?id=2669154261","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669154261?lang=en_us&edition=fundamental","pubTime":"2026-09-21 17:47","pubTimestamp":1789984022,"startTime":"0","endTime":"0","summary":"Novo Nordisk  is facing shareholder calls to develop new medicines and pursue acquisitions so that it could lower its dependence on its popular weight-loss treatments, the Financial Times reported Sunday, citing the company's investors.The Danish pharmaceutical giant's chief executive, Mike Doustdar, is under pressure to demonstrate that Novo can regain ground lost to key rival Eli Lilly  in the obesity drug market, according to the report.Novo will discuss topics, including research and development, at its capital markets day scheduled for Monday, the company said in a statement e-mailed to MT Newswires.Novo shares were down 6.1% in premarket activity Monday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4588","BK4585","NVOX","PPH","IE00BKVL7J92.USD","BK4532","IE00BZ1G4Q59.USD","BK4599","NVO","NVOC","NVOH","THNR","LU1093756325.SGD","LU1093756168.USD","OZEM","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669545011","title":"Pfizer Agrees to Share Incremental Overseas Drug Revenue With HHS","url":"https://stock-news.laohu8.com/highlight/detail?id=2669545011","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669545011?lang=en_us&edition=fundamental","pubTime":"2026-09-21 17:38","pubTimestamp":1789983525,"startTime":"0","endTime":"0","summary":"Pfizer  will share a portion of increased revenue from higher drug prices abroad with the US Department of Health and Human Services under a contract tied to the Trump administration's \"most favored nation\" pricing policy, according to newly released documents obtained by Public Citizen.The deal with Pfizer runs through Jan. 20, 2029, the consumer advocacy group said.The contract says HHS will use the funds to lower costs for US patients and taxpayers, without specifying more details.Pfizer and the White House did not immediately respond to MT Newswires' request for comment.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1057294990.SGD","LU1883839398.USD","SGXZ57979304.SGD","SG9999011175.SGD","IE00B19Z3581.USD","LU0456855351.SGD","SG9999013999.USD","LU0122379950.USD","BK4599","LU1894683264.USD","BK4585","LU1066051498.USD","LU0321505868.SGD","LU2596442595.SGD","BK4588","BK4007","LU0321505439.SGD","BK4533","IE00B3T34201.USD","BK4581","IE00BLSP4452.SGD","LU0234572021.USD","BK4592","SG9999001176.SGD","SG9999003800.SGD","LU0868494617.USD","LU0306807586.USD","LU0225771236.USD","LU0306806265.USD","LU0985481810.HKD","BK4568","PFE","BK4534","OZEM","SG9999002232.USD","IE00BLSP4239.USD","LU0170899867.USD","LU1894683348.USD","LU1066053197.SGD","SG9999002224.SGD","BK4550","IE00B19Z3B42.SGD","LU0289739699.SGD","IE00BBT3K403.USD","LU0225284248.USD","LU1023059063.AUD","IE0002270589.USD","SG9999001176.USD","LU0058720904.USD","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669154579","title":"Novo Nordisk Aims for $23 Billion in 2035 Pipeline Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2669154579","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669154579?lang=en_us&edition=fundamental","pubTime":"2026-09-21 17:38","pubTimestamp":1789983492,"startTime":"0","endTime":"0","summary":"Novo Nordisk  on Monday outlined long-term financial and pipeline targets, including plans for 150 billion Danish kroner  in pipeline sales in 2035 and the launch of at least five multi-blockbusters by 2030.The Danish company said it is targeting compounded annual revenue growth rates from 2026 to 2030 in line with industry peers.Novo Nordisk aims to scale capacity to serve 10 times more people with obesity on oral GLP-1s and more than 60 million patients by 2030, it said.The drugmaker also said it envisions maintaining a \"broadly stable\" operating margin and an \"attractive\" dividend per share.Shares of the company were down 6% in recent premarket trading.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVO","BK4007","BK4532","LU0154236417.USD","NVOH","IE00BKVL7J92.USD","OZEM","PPH","LU1093756168.USD","BK4585","BK4599","IE00BZ1G4Q59.USD","NVOC","NVOX","BK4588","THNR","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669748159","title":"Novo Nordisk Stock Tumbles as Ozempic Maker Sets Out 2030 Goals","url":"https://stock-news.laohu8.com/highlight/detail?id=2669748159","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669748159?lang=en_us&edition=fundamental","pubTime":"2026-09-21 16:58","pubTimestamp":1789981080,"startTime":"0","endTime":"0","summary":"Danish drugmaker says it aims to grow revenue in line with its leading rivalsNovo Nordisk CEO Mike Doustdar poses for a photo at Novo Nordisk headquarters in Bagsvaerd on August 5, 2026. The stock tum","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPH","BK4532","NVO","BK4588","NVOX","IE00BZ1G4Q59.USD","LU1093756168.USD","OZEM","BK4599","BK4007","LU0154236417.USD","BK4585","THNR","NVOC","LU1093756325.SGD","IE00BKVL7J92.USD","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669151392","title":"Wegovy Maker Novo Nordisk Targets Several New Blockbuster Drugs in Coming Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2669151392","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669151392?lang=en_us&edition=fundamental","pubTime":"2026-09-21 16:58","pubTimestamp":1789981080,"startTime":"0","endTime":"0","summary":"Novo Nordisk aims to launch several new blockbuster drugs in the next few years while expanding into further treatment areas, part of a new plan to revive growth that the Ozempic manufacturer outlined","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4532","NVOX","OZEM","NVO","BK4585","IE00BKVL7J92.USD","NVOC","PPH","THNR","BK4599","BK4007","NVOH","LU0154236417.USD","LU1093756325.SGD","LU1093756168.USD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669156720","title":"Sino Biopharmaceutical Stock Rises 8.2% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2669156720","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669156720?lang=en_us&edition=fundamental","pubTime":"2026-09-21 16:30","pubTimestamp":1789979400,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. rallied 8.2% to 5.92 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.2% to 25042.71.Sino Biopharmaceutical Ltd. closed 32% below its 52-week high of HK$8.65, which the company achieved Sept. 22.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 7.6% and Amgen Inc. remained unchanged.Trading volume totaled 150.2 million shares, compared to the 50-day average of 89.1 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU0109394709.USD","BK4581","LU1571399168.USD","IE00BZ08YS42.EUR","LU2468319806.SGD","LU2242652126.USD","IE0009355771.USD","IE00BZ08YR35.GBP","BIB","AMGN","IE00B4R5TH58.HKD","BK4585","BK4588","01177","BK1521","HK0000165453.HKD","IBB","IE00BJJMRZ35.SGD","LU1023059063.AUD","LU2112291526.USD","LU1057294990.SGD","IE0002141913.USD","IE00B2B36J28.USD","IE00BZ08YT58.USD","PBE","LU2242646821.SGD","BK4533","LU0289739699.SGD","IE00BJT1NW94.SGD","SG9999001440.SGD","LU0868494617.USD","LU1061106388.HKD","PJP","BK4534","BK4566","BK4599","IE00BFTCPJ56.SGD","BK1589","IBBQ","LU0058720904.USD","LU0320765992.SGD","LU0122379950.USD","LU1983299246.USD","LU2089984988.USD","BK4139","TBXU","BK1191","BK1515","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668184489","title":"Pfizer to share portion of increased revenue to U.S. HHS, Bloomberg says","url":"https://stock-news.laohu8.com/highlight/detail?id=2668184489","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668184489?lang=en_us&edition=fundamental","pubTime":"2026-09-20 23:10","pubTimestamp":1789917007,"startTime":"0","endTime":"0","summary":"The U.S. Department of Health and Human Services, HHS, will receive a portion of the increased revenue if Pfizer (PFE) raises its drug prices abroa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pfizer-to-share-portion-of-increased-revenue-to-u-s-hhs-bloomberg-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pfizer-to-share-portion-of-increased-revenue-to-u-s-hhs-bloomberg-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","IE00BLSP4239.USD","LU0058720904.USD","IE000M9KFDE8.USD","IE00B3T34201.USD","BK4588","SG9999011175.SGD","LU0321505868.SGD","SGXZ57979304.SGD","LU1894683264.USD","LU0170899867.USD","SG9999002232.USD","IE00BBT3K403.USD","IE00B19Z3581.USD","LU0306806265.USD","OZEM","LU1066051498.USD","LU1883839398.USD","SG9999013999.USD","IE0002270589.USD","IE00B19Z3B42.SGD","LU0306807586.USD","BK4533","LU2596442595.SGD","LU1894683348.USD","SG9999002224.SGD","BK4585","LU1057294990.SGD","LU0122379950.USD","BK4550","LU0234572021.USD","LU0321505439.SGD","BK4568","LU0456855351.SGD","LU0985481810.HKD","SG9999003800.SGD","SG9999001176.USD","BK4007","BK4592","PFE","LU0225771236.USD","LU1066053197.SGD","SG9999001176.SGD","BK4534","IE00BLSP4452.SGD","LU0225284248.USD","LU1023059063.AUD","LU0868494617.USD","BK4581","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668184620","title":"Eli Lilly, Novo sued over risk of sudden vision loss, WSJ reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2668184620","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668184620?lang=en_us&edition=fundamental","pubTime":"2026-09-20 22:55","pubTimestamp":1789916110,"startTime":"0","endTime":"0","summary":"Dozens of people are suing Novo Nordisk (NVO), claiming its weight-loss and diabetes drugs Wegovey and Ozempic caused their nonarteritic anterior i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eli-lilly-novo-sued-over-risk-of-sudden-vision-loss-wsj-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eli-lilly-novo-sued-over-risk-of-sudden-vision-loss-wsj-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TMED","IE0004445239.USD","IE0005OL40V9.USD","SG9999014880.SGD","LU0786609619.USD","ELIL","LU1868836591.USD","ILDR","LU0058720904.USD","LU0353189680.USD","LU0787776722.HKD","NVO","LU1280957306.USD","LU1366192091.USD","LU0320765059.SGD","IE00B4R5TH58.HKD","LU2746668974.SGD","LU0466842654.USD","SGXZ31699556.SGD","LU2168564149.EUR","BK4581","LU0889565916.HKD","GDOC","LU2028103732.USD","IE00BKVL7J92.USD","TRUH","LU1804176565.USD","LU2237438978.USD","LU0203202063.USD","LU0174119429.USD","IE00BZ1G4Q59.USD","LU0289739699.SGD","IE00B775H168.HKD","LU0823416689.USD","LU2236285917.USD","IE00BJJMRY28.SGD","LU2361045086.USD","LU2491050071.SGD","SG9999014906.USD","BK4533","SGXZ51526630.SGD","LU1057294990.SGD","LU0882574055.USD","LU2417539215.USD","LU0471298694.HKD","LU2108987350.USD","LU2756315318.SGD","LU2089283258.USD","LU2361044949.HKD","LU2471134952.CNY","LU0689472784.USD","IE00BWXC8680.SGD","BK4516","SG9999017495.SGD","BK4534","LU2168564065.EUR","SG9999015978.USD","SGXZ99366536.SGD","LU0943347566.SGD","LU2023250504.SGD","LU1623119135.USD","SG9999001176.SGD","LU1127390331.HKD","LU1232071149.USD","LU0708995401.HKD","LU2552382215.SGD","LU1988902786.USD","LU2265009873.SGD","NVOH","LU2361044865.SGD","LU2112291526.USD","LU0109394709.USD","LU0354030511.USD","LU1267930730.SGD","LU0061475181.USD","MEDX","LU0096364046.USD","LU2756315664.SGD","IE00BJJMRX11.SGD","LU0203201768.USD","IE00BJLML261.HKD","LU2746668461.USD","LU0154236417.USD","LU1548497426.USD","LU1989771016.USD","LU0225283273.USD","IE00B7KXQ091.USD","LU2471134523.USD","LU0079474960.USD","LU1720051017.SGD","LU2461242641.AUD","IXJ","IE0009355771.USD","LU0158827948.USD","VHT","LU0256863902.USD","FHLC","FTXH","LU0672654240.SGD","LU0097036916.USD","IE00BJT1NW94.SGD","LU2471134879.HKD","LU2360106947.USD","BK4007","LU0114720955.EUR","GB00BDT5M118.USD","LU0133085943.USD","LU0345770308.USD","LU2168564222.USD","LU2462157665.USD","LU2750360997.AUD","LU0106261372.USD","LU0266013472.USD","LU2111349929.HKD","SG9999013999.USD","LU1023059063.AUD","SG9999018865.SGD","LU2552382132.HKD","LU0234572021.USD","LU2462591350.SGD","IE00BFTCPJ56.SGD","OZEM","LU2168563687.JPY","LU2237443382.USD","SG9999014898.SGD","IE00B1BXHZ80.USD","IE00BKPKM429.USD","LU0964807845.USD","LU1093756325.SGD","LU2264538146.SGD","LU0210536198.USD","PPH","LU2023250330.USD","IHE","LU2237443465.HKD","LU1061106388.HKD","LU0823434740.USD","LU1720051108.HKD","JDOC","AGNG","IE0001KFT4U8.USD","LU2468319806.SGD","LU0683600562.USD","LU1069344957.HKD","IE00B4JS1V06.HKD","LU2089984988.USD","LU0256863811.USD","LU1868837300.USD","LU2168564495.EUR","IE00BK4W5L77.USD","NVOX","SG9999014914.USD","LU0820561909.HKD","LU2491049909.HKD","LU1868836914.USD","LU2211815571.USD","LU2213496289.HKD","LU1323610961.USD","SG9999018857.SGD","SGXZ57979304.SGD","LLYZ","LU0417517546.SGD","CANC","THNR","SG9999015945.SGD","LU2023251221.USD","LU1868836757.USD","LU2271345857.HKD","LU2471134796.USD","CURE","LU1629891620.HKD","LU2602419157.SGD","BK4599","LU0323591593.USD","MEDI","LLII","LU1974910355.USD","LU1064131342.USD","LU1035775433.USD","LU1712237335.SGD","LU0823434583.USD","IYH","LU0320765992.SGD","LU0432979614.USD","IE00BKDWB100.SGD","LU2357305700.SGD","ELIS","IE00BFSS8Q28.SGD","SG9999015952.SGD","LU2087625088.SGD","LU2896262040.SGD","LU1983299246.USD","LLY","LU1814569148.SGD","LU2750360641.GBP","LU1691799644.USD","LU2237443895.HKD","WDNA","PJP","LU0122379950.USD","LU0471298777.SGD","SGXZ81514606.USD","LU1291159041.SGD","LU0385154629.USD","LU0353189763.USD","LU0456855351.SGD","LU2456880835.USD","BK4585","LU1145028129.USD","LU1868837136.USD","LU1551013425.SGD","LU1093756168.USD","LU2324357040.USD","LU2552382058.USD","LU2237443549.SGD","HRTS","IE00BFSS7M15.SGD","IE00BJJMRZ35.SGD","BK4532","RXL","SG9999001176.USD","IE00B2B36J28.USD","LU1551013342.USD","LU0238689110.USD","LU2491050154.USD","BK4588","LU0109391861.USD","LU1979441026.SGD","LU0198837287.USD","LU2106854487.HKD","IE0004445015.USD","NVOC","LU0006306889.USD","LU0820561818.USD","LU0820562030.AUD","IE00BN29S564.USD","LU1917777945.USD","MHIP","LU0158827781.USD","LU0640476718.USD","LU2237443978.SGD","LU0354030438.USD","LU0882574139.USD","LU2089284900.SGD","IE00B1XK9C88.USD","IE00BK4W5M84.HKD","XLV","LU0316494557.USD","LLYX","LU2237443622.USD","SG9999015986.USD","LU2063271972.USD","LU0345770993.USD","LU0094547139.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668090722","title":"Will Conference Outlook Change Pfizer (PFE) Stock Narrative","url":"https://stock-news.laohu8.com/highlight/detail?id=2668090722","media":"Simply Wall St.","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668090722?lang=en_us&edition=fundamental","pubTime":"2026-09-20 09:26","pubTimestamp":1789867569,"startTime":"0","endTime":"0","summary":"Pfizer recently presented at the Morgan Stanley 24th Annual Global Healthcare Conference in New York, with CEO Albert Bourla outlining how the business is handling debt, patent expiries, and future product opportunities.\nThe discussion put a spotlight on how Pfizer balances a large dividend outlay and more than US$60b of acquisition driven debt with the need to fund its oncology, obesity, and vaccine pipelines.\nWe will now look at how Pfizer's investment narrative could be affected by CEO...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/162270-card/1788974859487","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/162270-card/1788974859487"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-pfe/pfizer/news/will-conference-outlook-change-pfizer-pfe-stock-narrative","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-pfe/pfizer/news/will-conference-outlook-change-pfizer-pfe-stock-narrative","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BLSP4239.USD","IE00B3T34201.USD","LU1066053197.SGD","OZEM","LU1023059063.AUD","IE000M9KFDE8.USD","LU0122379950.USD","IE00BLSP4452.SGD","SGXZ57979304.SGD","LU0306806265.USD","LU0289739699.SGD","LU0321505868.SGD","BK4599","SG9999002224.SGD","SG9999002232.USD","LU2596442595.SGD","SG9999001176.SGD","IE00B19Z3B42.SGD","BK4007","BK4592","LU0225284248.USD","LU0225771236.USD","IE0002270589.USD","LU0306807586.USD","LU0321505439.SGD","LU0868494617.USD","SG9999013999.USD","BK4568","LU0058720904.USD","IE00BBT3K403.USD","LU1057294990.SGD","LU1883839398.USD","BK4550","LU0456855351.SGD","LU0985481810.HKD","BK4588","LU1894683264.USD","LU1066051498.USD","LU1894683348.USD","PFE","SG9999011175.SGD","SG9999003800.SGD","BK4533","IE00B19Z3581.USD","BK4581","BK4585","SG9999001176.USD","LU0234572021.USD","LU0170899867.USD","BK4534"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":15,"pageCount":15,"totalSize":296,"code":"91000000","status":"200"}]}}